Picture of Inspiration Healthcare logo

IHC — Inspiration Healthcare News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Inspiration Health - Directorate Change

RNS Number : 9405Z

Inspiration Healthcare Group PLC

19 September 2025

 

 

 

19 September 2025

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Board Change

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces that Liz Shanahan, Non-Executive Director, has informed the Board that she will retire from the Board on 20 November 2025 at the end of the meeting scheduled to be held on that day. The Company does not intend to replace this position but will instead keep the composition of the Board under review. Richard Jones has agreed to take over as Chair of the Remuneration Committee following Liz's departure.

 

Roy Davis, Chair, said: "On behalf of the Board, I would like to thank Liz for her dedication and commitment to Inspiration Healthcare throughout her time on the Board. We wish Liz every success in her future endeavours."

 

For further information, please contact:

 

Inspiration Healthcare Group plcTel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer
Alan Olby, Chief Financial Officer
Panmure Liberum (Nominated Adviser & Broker)Tel: +44 (0)20 3100 2000
Emma Earl
Will Goode
Mark Rogers
Walbrook PR Ltd (Media and Investor Relations)Tel: +44 (0)20 7933 8780 orinspirationhealthcare@walbrookpr.com
Anna DunphyMob: +44 (0) 7876 741 001
Rachel BroadMob: +44 (0) 7747 515 393
  About Inspiration Healthcare   Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.   The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.   The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.   The Company operates in the UK from its Manufacturing and Technology Centre in Croydon, South London, and in the USA from its facility in Melbourne, Florida.   Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com     This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     BOABSGDCXUBDGUI

Recent news on Inspiration Healthcare

See all news